Editorial: risky business. What do sufferers' perceptions of risk from interventions for irritable bowel syndrome really mean?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1218-1219
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume55
Issue number9
DOIs
StatePublished - May 2022

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this